Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER vs ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Electrolyte and fluid replacement; dextrose provides caloric support.
Isolyte H in Dextrose 5% provides a balanced electrolyte solution with glucose to maintain fluid and electrolyte homeostasis. Dextrose is metabolized to carbon dioxide and water, providing calories. Electrolytes replenish losses and maintain acid-base balance.
Fluid and electrolyte replenishment,Correction of metabolic acidosis,Intravenous source of calories
Fluid and electrolyte replacement,Maintenance of hydration and electrolyte balance in patients unable to tolerate oral intake,Correction of hypovolemia,Mild to moderate metabolic acidosis
Intravenous infusion; rate based on fluid and electrolyte requirements, typically 1-2 m L/kg/hour for maintenance in adults.
Intravenous infusion; rate determined by clinical condition, electrolyte requirements, and fluid balance. Typical adult maintenance: 100-200 m L/hour. Maximum infusion rate: 1000 m L/hour.
Not applicable; components are endogenous substances. Dextrose has a plasma half-life of approximately 1.5-2.5 hours in normal glucose metabolism; electrolytes have half-lives dependent on renal function (e.g., sodium half-life ~1-2 days).
Not applicable as a fixed drug. Electrolytes have no defined half-life; dextrose is rapidly cleared with a metabolic half-life of approximately 5-10 minutes due to insulin-mediated uptake.
Dextrose is metabolized via glycolysis and oxidative phosphorylation; electrolytes are absorbed and excreted by the kidneys.
Dextrose is metabolized via glycolysis and the citric acid cycle to carbon dioxide and water, primarily in the liver; insulin promotes cellular uptake. Electrolytes are not metabolized but are excreted or reabsorbed by the kidneys.
Renal excretion of water and electrolytes; dextrose is metabolized to CO2 and water. >90% of water and electrolytes are excreted renally; dextrose is fully metabolized.
Electrolytes and dextrose are primarily excreted renally. Potassium, sodium, chloride, and magnesium are eliminated via kidneys. Dextrose is metabolized to CO2 and water, with negligible renal excretion. Biliary/fecal elimination is minimal (<5%).
Minimal (<5%); electrolytes are not significantly protein-bound; dextrose does not bind to proteins.
Negligible for electrolytes and dextrose (<5%).
Electrolytes distribute to total body water (~0.6 L/kg); dextrose distributes to extracellular fluid initially (~0.2 L/kg) then intracellularly.
Not applicable as a single compound. Electrolytes distribute primarily in extracellular fluid (0.2 L/kg for sodium), total body water (0.6 L/kg for water). Dextrose distributes in total body water (0.55 L/kg).
Intravenous: 100% bioavailability.
Intravenous: 100%.
No specific dose adjustment; monitor fluid and electrolyte status closely in renal impairment due to risk of volume overload and electrolyte disturbances.
No specific dose adjustment required; monitor serum electrolytes and fluid status in renal impairment due to risk of hyperkalemia, hypernatremia, or fluid overload.
No specific dose adjustment; monitor for fluid overload and electrolyte imbalances due to potential altered metabolism.
No specific dose adjustment; use with caution in severe hepatic impairment due to potential for fluid and electrolyte disturbances.
Intravenous infusion; rate based on weight: 100 m L/kg/day for first 10 kg, 50 m L/kg/day for next 10 kg, and 20 m L/kg/day for each kg above 20 kg.
Weight-based: 2-6 m L/kg/hour or as per Holliday-Segar method for maintenance; monitor serum electrolytes closely.
Use with caution; consider lower infusion rates due to decreased renal function and risk of fluid overload; monitor electrolytes and renal function closely.
Use with caution; consider lower initial rates due to reduced renal function and increased risk of fluid overload; monitor electrolytes and volume status.
Not for use in patients with hyperglycemia or certain electrolyte imbalances; solutions containing aluminum may be toxic with prolonged use in renally impaired patients.
None for this product; however, caution is required in patients with congestive heart failure, renal impairment, or conditions predisposing to electrolyte imbalances.
Monitor serum electrolytes, fluid balance, blood glucose; risk of hyperglycemia, hypokalemia, fluid overload; avoid in patients with renal impairment or heart failure.
Risk of fluid overload in patients with compromised cardiac or renal function,Risk of electrolyte imbalances (hyperkalemia, hyponatremia, hypernatremia),Administration may cause phlebitis or thrombosis,Monitor serum electrolytes, glucose, and fluid balance,Use with caution in patients with diabetes or glucose intolerance,Not for use when hyperosmolality is present
Hyperkalemia, hypernatremia, hyperglycemia, severe metabolic acidosis, anuria, or hypersensitivity to any component.
Hyperkalemia,Severe renal impairment (oliguria or anuria),Severe metabolic alkalosis,Hypersensitivity to any component,Patients with known glucose-6-phosphate dehydrogenase deficiency (relative, due to potential for Heinz body formation)
No direct food interactions. However, dietary intake of electrolytes (e.g., potassium, sodium) should be considered in patients receiving this solution. Avoid high-potassium foods if hyperkalemia is a concern.
No known food interactions. However, monitor dietary intake of sodium, potassium, and chloride to avoid electrolyte imbalances.
Dextrose 5% and electrolyte solutions (Isolyte R) are generally considered low risk. No specific teratogenic effects known. First trimester: no evidence of malformations. Second/third trimester: use as needed for fluid/electrolyte balance. Dextrose may cause maternal hyperglycemia, which can affect fetal glucose and insulin levels, potentially leading to fetal hyperinsulinism and neonatal hypoglycemia if maternal glucose is poorly controlled.
Isolyte H in Dextrose 5% is a balanced electrolyte solution with multiple electrolytes and 5% dextrose. Teratogenic risk: minimal due to components being normal physiological constituents. However, maternal hyperglycemia from dextrose may increase fetal risks including macrosomia and congenital anomalies if glucose not controlled. First trimester: no direct teratogenicity, but dextrose-induced hyperglycemia may be associated with neural tube defects. Second/third trimester: risk of fetal hyperinsulinemia, macrosomia, neonatal hypoglycemia if maternal glucose elevated.
Isolyte R in Dextrose 5% components (dextrose, electrolytes) are normal constituents of breast milk. No known adverse effects. M/P ratio not applicable as dextrose and electrolytes are endogenous substances. Use is considered compatible with breastfeeding.
Components are normal constituents of human milk. No specific M/P ratio data; dextrose, sodium, potassium, magnesium, chloride, acetate, gluconate are expected to transfer minimally. Use is compatible with breastfeeding. Monitor infant for electrolyte balance only if maternal levels are abnormal.
No specific dose adjustments required for pregnancy. However, due to increased plasma volume and glomerular filtration rate in pregnancy, individualize based on fluid and electrolyte needs. Monitor for hyperglycemia, which may require dose reduction or insulin therapy. Use caution in preeclampsia or impaired renal function.
Pregnancy increases plasma volume and glomerular filtration rate; may require higher infusion rates to achieve desired electrolyte balance. Dextrose load may need adjustment to avoid maternal hyperglycemia, especially in gestational diabetes. No dose changes for electrolyte components themselves; monitor clinical response and serum levels.
ISOLYTE R in Dextrose 5% is an isotonic solution used for fluid and electrolyte replacement. Monitor serum glucose and electrolytes, especially in diabetic patients. Avoid in patients with hyperglycemia, hyperkalemia, or hyperlactatemia. Use with caution in renal impairment. The solution contains 130 m Eq/L sodium, 4 m Eq/L potassium, 3 m Eq/L calcium, 1 m Eq/L magnesium, 109 m Eq/L chloride, 28 m Eq/L lactate, and 5% dextrose. It provides 170 kcal/L. Do not administer simultaneously with blood products through same line.
ISOLYTE H IN DEXTROSE 5% is a hypertonic solution (approximately 554 m Osm/L) that provides free water, electrolytes, and calories. Use caution in patients with renal impairment or those at risk for fluid overload. Monitor serum sodium, potassium, chloride, and glucose levels during infusion. Do not administer if solution is discolored or contains particulate matter. Compatible with most IV lines but avoid adding other drugs without checking compatibility.
Inform your healthcare provider if you have diabetes, kidney problems, or heart failure.,Report any signs of fluid overload (swelling, difficulty breathing) or electrolyte imbalance (muscle cramps, weakness, irregular heartbeat).,This solution contains sugar; monitor blood glucose if you have diabetes.,Do not use if the solution is cloudy or contains particles.
This solution is given through a vein to provide fluids, electrolytes, and sugar.,Tell your healthcare provider if you have kidney problems, heart issues, or if you are on a low-sodium or low-potassium diet.,Report any signs of fluid overload such as swelling, shortness of breath, or rapid weight gain.,You may need blood tests to check your body's electrolyte levels and blood sugar.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER vs ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER, answered by our medical review team.
ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER is a Intravenous Electrolyte Solution that works by Electrolyte and fluid replacement; dextrose provides caloric support.. ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER is a Intravenous Electrolyte Solution with Dextrose that works by Isolyte H in Dextrose 5% provides a balanced electrolyte solution with glucose to maintain fluid and electrolyte homeostasis. Dextrose is metabolized to carbon dioxide and water, providing calories. Electrolytes replenish losses and maintain acid-base balance.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER and ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER depend on the specific clinical indication. These are agents from distinct pharmacological classes and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER is: Intravenous infusion; rate based on fluid and electrolyte requirements, typically 1-2 m L/kg/hour for maintenance in adults.. The standard adult dose of ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER is: Intravenous infusion; rate determined by clinical condition, electrolyte requirements, and fluid balance. Typical adult maintenance: 100-200 m L/hour. Maximum infusion rate: 1000 m L/hour.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER and ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER is classified as Category C. Dextrose 5% and electrolyte solutions (Isolyte R) are generally considered low risk. No specific teratogenic effects known. First trimester: no evidence of malformations. Second/th. ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER is classified as Category C. Isolyte H in Dextrose 5% is a balanced electrolyte solution with multiple electrolytes and 5% dextrose. Teratogenic risk: minimal due to components being normal physiological const. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.